While benzocaine can be effective, its use in children, especially those under two years old, is controversial. The FDA has issued warnings concerning the potential risks of benzocaine in young children, including a rare but serious condition called methemoglobinemia. This condition reduces the amount of oxygen carried in the blood and can be life-threatening.
